Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCRX-201 in Painful Osteoarthritis of the Knee
NCT06884865Phase 2Recruiting
- Sponsor
- Pacira BioSciences
- Start
- Feb 2025
- Primary completion
- Nov 2026
- Modality
- Gene Editing, Gene Silencing, Gene Addition/Replacement
- Countries
- 1
01
Overview
A Phase 2 trial of enekinragene inzadenovec in osteoarthritis (OA), sponsored by Pacira BioSciences. Started Feb 2025; status: recruiting.
02
Drugs
enekinragene inzadenovec
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06884865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06884865.